Growth regulation and co-stimulation of human colorectal cancer cell lines by insulin-like growth factor I, II and transforming growth factor alpha. by Lahm, H. et al.
Br. J. Cancer (1992). 65, 341 346 © Macmillan Press Ltd.. 1992
Growth regulation and co-stimulation of human colorectal cancer cell
lines by insulin-like growth factor I, II and transforming growth factor a
H. Lahm'. L. Suardet', P.L. Laurent', J.R. Fischer2, A. Ceyhan', J.-C. Givel3 & N. Odartchenko'
'Sw iss Institutefor Experimental Cancer Research, Department ofCellular Biology, Chemin des Boveresses 155, CH-1066
Epalinges, Swit:erland; 2Thoracic Clinic, Department ofClinical Oncologv, Amalienstrasse 5, D-W-6900 Heidelberg-Rohrbach,
Germany and 3CHL'V, Department ofSurgery, CH-1011 Lausanne, Switrerland.
Summar We have tested growth factor responsiveness of a panel of eight human colorectal carcinoma cell
lines. Insulin-like growth factors I and II (IGF-I and IGF-II) stimulated growth of five lines (HT-29. LS41 IN.
LS513. SW480. WiDr). At 30 ng ml- 'both factors enhanced growth up to 3-fold. Thev induced half-maximal
stimulation at 1.9-6.51 ng ml-'. Even after delayed addition IGF-I and II sigmnficantly enhanced growth in a
short-term proliferation assay. They exerted maximal effects under limiting serum conditions (0.50o FCS) and
at low cell density (1.25 -5 x I10 ml '. Using these conditions transforming growbth factor m (TGFcx) enhanced
proliferation of all IGF-responsive cell lines, except SW480. 1.11 -3.31 ng ml-' were required to obtain a
half-maximal response. With 10-20 ng ml ' maximal stimulation occurred at plateau values different from
those for IGF-I II. Proliferation of all cell lines responsive to both IGF-I and TGFm was further enhanced bv
combining both factors. resulting a synergistic response of LS513, while the effects on HT-29. LS41 IN and
WiDr were additive. With HT-29 and LS41IN a 24 h exposure to TGFm was sufficient to obtain a full
response in the co-stimulatorv assav. Our results illustrate the importance of IGF-I II and TGFx as
stimulators of growth of colorectal carcinomas.
Colorectal carcinoma is one of the most frequently occumrng
human malignant neoplasms. However, the growth regu-
lation of these tumours remains only partially understood.
The establishment of continuous cell lines derived from
pnmary tumours made it possible to study putative mechan-
isms in further detail. Yet, no common picture has so far
emerged, while a number of hormones have been reported to
influence growth of colorectal carcinomas (Hoosein et al..
1990). and so have vanrous growth factors (Hoosein et al..
1987; Rodeck et al.. 1987) and cytokines (Berdel et al.. 1989:
Tsai & Gaffney. 1987). Depending on the differentiation
status, one molecule may exert different effects (Mulder et al..
1990) and even the same cell line may respond in different
ways to a single growth factor (Pignatelli & Bodmer. 1989:
Mulder et al.. 1988). Apart from soluble mediators the
growth of colorectal carcinomas is impaired by tumour sup-
pressor genes (Tanaka et al.. 1991: Baker et al.. 1990) and
dysregulated oncogenes (Forgue-Lafitte et al.. 1989).
We have focused our work on the role of insulin-like
growth factors I and II (IGF-I and IGF-II) and transforming
growth factor a (TGFcz) in stimulating grow%th of colon car-
cinomas. Both IGF-I and II (Macaulay et al.. 1990: El-Badry
et al.. 1989) as well as TGFa (Markowitz et al.. 1990:
Ohmura et al.. 1990) stimulate growth of various tumour
cells. For all three factors specific messenger RNAs were
detected in colon carcinomas (Coffev et al.. 1987: Tricoli et
al.. 1986) and the presence of molecules. similar or identical
to IGF-I. epidermal growth factor (EGF) and TGFx has
been demonstrated in the supernatant of several cell lines
(Anzano et al.. 1989; Culouscou et al.. 1987). In addition.
colon carcinomas express receptors for IGF-I (Durrant et al..
1991) and for TGFcx EGF (Coffey et al.. 1987).
In the present study we show that IGF-I. IGF-I1 and
TGFa are potent stimulators of colorectal carcinoma cell
proliferation in vitro. The majority of the cell lines that we
studied responded to IGF-I and IGF-II and four out of eight
could also be stimulated by TGFx. In addition. we provide
evidence that co-stimulation with IGF-I and TGFa further
enhances the response obtained with either growth factor
alone.
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Miaterials and methods
Culture medium
Cell lines were cultured in a 1:1 mixture of Dulbecco's
Modified Eagle Medium (GIBCO. Basel. Switzerland. 074-
01600) and Nutrient Mixture Ham's F-12 (GIBCO. 074-
01700) supplemented with HEPES (10 mM final concentra-
tion). L-glutamine (1.4 mM final concentration). penicillin
(100 Uml') and streptomycin (l00sgmml'). This medium is
referred to below as EF medium.
Cell lines and culture conditions
We have used a panel of eight human colorectal cancer cell
lines. which have been derived from primary tumours: Co-
115. HT-29 (ATCC: HTB38). SW480 (ATCC: CCL228).
WiDr (ATCC: CCL218) and Lisp-l (obtained from Dr D.
Lopez. Ludwig-Institut for Cancer Research. Sao Paulo.
Brazil). The cell lines LS41IN. LS513 and LS1034 have been
established in our own laboratorv (Suardet et al.. 1990). All
cell lines were cultured in EF medium with 50 FCS (Sero-
med. Berlin. Germany) and supplements as described by
Suardet et al. (1989).
Reagents andgrow-thfactors
3-[4.5-Dimethylthiazol-2-yl]-2.5-diphenyltetrazolium bromide
(MTT) was purchased from Sigma (Munich. Germany). dis-
solved in PBS (5mgm1-') and kept at -20°C until further
use. Recombinant human (rhu) IGF-I and rhu IGF-II were
purchased from AMS Biotechnology (Lugano. Switzerland).
Svnthetic hu TGFax was obtained from Biotope (Seattle.
WA). Purity of growth factors was >98006.
Assayfor the assessment ofproliferation ofcolorectal
carcinoma cell lines
The proliferation of colorectal carcinoma cell lines was
assessed in EF medium supplemented with 0.5% FCS. The
cells were washed with PBS and cell suspensions were ob-
tained by trypsinising monolayer cultures with 0.05% tryp-
sin 0.02% EDTA (Seromed). then cells were washed with EF
medium and resuspended in EF medium containing 0.5%
FCS. Cells were distributed at 2.5 x I03 (SW480). 5 x 10-
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(HT-29, Lisp-i, WiDr) or l x I04 cells well (Co-115, LS
41 IN, LS513, LS1034) into 96-well flat-bottomed microtiter
plates (Nunc, Roskilde, Denmark) in a final volume of 200 il
EF medium containing 0.5% FCS. Cells were incubated for 4
(HT-29, Lisp-i, LS41IN, SW480, WiDr) or 5 days (Co-115.
LS513, LS1034) at 37C and 5% CO, in the presence or
absence of growth factors. Proliferation was assessed by
measuring the conversion of MTT to a formazan product
during the last 4 h of culture (see below). All samples were
measured in triplicate. All results have been confirmed in at
least three independent experiments.
MIT assay
The original MTT assay of Mosmann (1983) was used with
several modifications (Twentyman & Luscombe, 1987; Deni-
zot & Lang, 1986). Bnrefly, the culture medium was aspirated
and 100 id of MTT (diluted to a final concentration of
0.5mgml-' in EF medium) were added. The cells were
incubated for another 4 h at 37C and 5% CO,. The MTT-
solution was aspirated and 200;Ll of DMSO were added to
dissolve formazan. The well contents were thoroughly mixed
and the plates were read immediately at 570 nm using an
MR5000 ELISA reader (Dynatech, Embrach-Embraport.
Switzerland). The reference wavelength was set at 690nm.
Kinetic experiments
The cells were cultured under the same conditions as above
for the proliferation assay.
Kinetic experiment for IGF-I II rhu IGF-I or IGF-II were
added on day 0 and then every other day at a concentration
of 10ngml['. The OD at 570nm obtained upon culture of
cells in EF medium containing 0.5% FCS was defined as a
proliferation of 100%. The response obtained by adding IGF
on following days is expressed as per cent proliferation com-
pared to this value. All samples were measured in trplicate.
Kinetic experiments for the action of TGFx in the co-stim-
ulator) assaj( Cells were cultured in the presence of subop-
timal concentrations of IGF-I throughout the experiment.
The following concentrations of IGF-I were used: 10 ng ml-'
(LS513), 5 ng ml-' (LS41 1N) and 2.5 ngml-' (HT-29, Wi
Dr). TGFcx (3 ng ml-') was added on day 0 and then every
other day. The response obtained by adding TGFa on fol-
lowing days was calculated as above for the kinetic experi-
ment for IGF-I/II. All samples were measured in triplicate.
Mycoplasma testing
After periodical testing using standard culture procedures
(Myco Tect, GIBCO), all cell lines were consistently found to
be free of Mycoplasma contamination.
Thus, we have employed these conditions in all further
experiments.
Proliferation of five cell lines (HT-29, LS41IN, LS513,
SW480, WiDr) was enhanced by both IGF-I and IGF-II
under these conditions, while Co-i 15, Lisp-I and LS1034 did
not respond to either factor. The dose-response curves of
IGF-I and IGF-II were similar in shape for all responsive cell
lines. A representative dose-response obtained with WiDr
cells is shown in Figure 1. The optimal response with all
responsive cell lines was achieved with an IGF concentration
of approximately 30 ng ml-'. Maximal stimulation varied
from 1.5-fold (LS513. SW480) to about 3-fold (LS41IN).
both factors being equally effective (Table I). Between 1.9
and 5.11 ngml-' of IGF-I and 3.07-6.51 ngml-1 of IGF-II
were required to obtain a half-maximal response. In this
respect. IGF-I was slightly more active than IGF-II on each
of the cell lines tested (Table I). In addition, we have used
the same conditions to test the effect of insulin on the HT-29
cell line. Insulin also stimulated the growth of HT-29. How-
ever, to obtain a half-maximal response much higher doses
were required (approximately 35 times the amount of IGF-I)
(data not shown).
The effect ofIGF-I II is mostpronounced at low serum
concentrations
To further define the conditions under which IGF-I II stim-
ulates growth of human colorectal cancer cell lines, we have
tested the effect of growth factors using varying serum condi-
tions. Up to 2% FCS, proliferation of HT-29 cells was
enhanced significantly. However, the most prominent stimu-
latory effect was obtained when limiting serum conditions
were used. Addition of IGF-I or IGF-II to cells cultured in
medium containing only 0.5% FCS, resulted in growth-rate
values very close to the proliferation rate of cells cultured
with 5% FCS (Figure 2). Under these conditions the cells
grew as long-term cultures, dividing at maximum speed, and
the addition of exogenous growth factors did not stimulate
proliferation significantly. The same results have been ob-
tained with the other IGF-responsive cell lines.
Induction ofgrowth by IGF-IIII is dependent on cell density
In order to determine whether cell density influenced IGF
responsiveness, we have measured the effects of IGF-I/II at
different cell concentrations. IGF-I and II stimulated pro-
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Statistical analvsis
Significance of differences between responses to growth fac-
tors and untreated control cells was calculated using the
Student's t-test.
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Results
IGF-I and IGF-II stimulate proliferation ofhwnan colorectal 0.0
cancer cell lines
We have tested a series of eight human colorectal cancer cell
lines for growth factor responsiveness to IGF-I and IGF-II, Fignm 1 IGF-
using culture conditions which significantly reduced cell cinoma cells. M
growth rate. To determine the time at which the effect of IGFI (U) or
IGF was maximal, we have recorded the response of a ug the M
rapidly (doublng time <24 h) and a slowly growing (doub- ediresnt the8
ling time >24 h) cell line daily for 1 week. A period of4 and P<0.005 from
5 days, respectively, proved to be optimal (data not shown). ml-'.
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Table I Responsiveness of colorectal cancer cell lines to IGF-I, IGF-II and TGFx
HT-29 LS411N LS513 WiDr SW480
IGF-I Si,' 2.40 ± 0.42 2.85 ± 0.37 1.65 ± 0.13 2.59 ± 0.76 1.39 ± 0.21
ED5o (ng ml-')b 1.90 0.77 5.11 2.14 3.61 2.10 3.35 0.40 2.54 1.19
IGF-II SIM= 2.22 ± 0.51 2.97 ± 0.26 1.54 ± 0.06 2.43 ± 0.76 1.46 ± 0.14
ED50 (ng ml-') 3.07 0.50 6.51 ± 0.98 6.21 ± 2.82 4.71 ± 1.01 3.64 1.88
TGFcx SI, 1.50 0.19 1.86 0.22 2.03 0.27 1.47 0.19 NR
ED50(ng ml-') 2.20 0.49 3.31 ±0.97 1.11 ±0.86 1.88 1.34 NR
Growth stimulationwasdetermined using theproliferation assay. All results representthemean of
three independent experiments. a: Maximal stimulation-index. The value was calculated by dividing
the OD at 570 nm in the presence ofgrowth factors by the OD at 570 nm in the presence ofculture
medium. b: Concentration of growth factor required to obtain a half-maximal response. NR: not
responsive.
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Fue 2 IGF-mediated growth stimulation is most pronounced
at low serum levels. HT-29 cells were cultured in the presence of
culture medium (A), rhu IGF-I (1Ong ml-'. *) or rhu IGF-II
(10 ng ml-', 0) at different concentrations of FCS. Proliferation
was determined using the MTT assay. Values represent the mean
of quadruplicates with an s.d. below 10% P<0.003. *not
significant.
liferation at cell concentrations which covered a range of
about one log1o. However, both the range and the cell density
optimal for inducing growth differed from one line to
another. LS411N (Figure 3) and LS513 responded best at
5 x I04 cells ml -'. The rapidly growing SW480 line exhibited
an optimal response at 1.25 x I0W cells ml-', whereas for
HT-29 and WiDr this concentration was approximately
2.5 x I04 cells ml-' (data not shown). With increasing cell
concentrations. each line reached an upper limit after which
the addition of IGF no longer stimulated growth. The latter
value varied from 0.5 x I05 ml-' for SW480 to 2 x I05 cells
ml-' for LS4llN cells (Figure 3). Exceeding this threshold
resulted at times in a slight decrease in proliferation. prob-
ably due to cell overgrowth and accumulation of toxic
metabolites.
Kinetics ofthe proliferation induced b.v IGF-I and IGF-II
We also investigated the kinetics of action of IGF-I and II in
the short-term proliferation assay, determining the changes in
response when the addition of growth factors was delayed. If
IGF-II was added 24 h after the onset of the experiment.
proliferation was only slightly decreased, an exception being
the LS513 line, in which the response was reduced by about
one third (Table II). In contrast, the addition of IGF-II to
LS41 IN cells could even be delayed by 48 h without reducing
the extent of the response. A significant decrease in prolifera-
tion was seen with all cell lines if the factor was present
during the last 24 h only (Table II). However, even such
short-term exposure was sufficient to induce a significant
1.25 2.5 5 10 20
Cells ml-' (x 10-4)
40
Figure 3 Cell density critically influences the response to IGF-I
and IGF-II. LS41IN cells were cultured in the presence of culture
medium containing 0.5% FCS (A). rhu IGF-I (1Ongml-', U)
or rhu IGF-II (10ngml-1. 0) at different cell concentrations.
Proliferation was determined using the MTT assay. Values repre-
sent the mean of tnplicates with an s.d. below 10%. P<0.02.
*not significant.
Table II Effect of delayed addition on the response to IGF-II
Addition offactor on dav
0 1 2 3 4
HT-29a 182±20 185± 9 170± 8 149 12 -
LS41INb 160 21 171 15 165 10 136 6 -
LS513' 153 12 133 7 133 6 124 7 116 ± 3
SW480a 176 13 169 17 166 16 132 6 -
WiDrb 215 29 194 16 194 16 133 11
Responses to IGF-II are expressed as o proliferation ± s.d. in
comparison to untreated control cells. Results represent the mean of
three independent experiments. ap<0.005. bP< 0.02 from untreated
control cells.
response on all cell lines (P<0.005). Similar results have
been obtained in experiments with IGF-I (data not shown).
Effect of TGFcx on proliferation ofhuman colorectal cancer cell
lines
The good responsiveness of the colorectal carcinoma cell
lines to IGF-I and II enabled us to define an optimal
environment for growth stimulation. We have thus tested the
effect of other growth factors under the same conditions:
four of the five lines, which responded to IGF-I and IGF-II,
could also be stimulated by TGFa, whereas SW480 did not
respond (Figure 4). However, the stimulation obtained with
TGFx on HT-29, LS41 IN and WiDr was significantly lower
than the responses to IGF-I and IGF-II. In contrast, TGFa
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Figure 4 TGFcx promotes growth of colorectal carcinoma cell
lines. HT-29 (-). LS4llN (A). LS513 (A). SW480 (O) and
WiDr cells (0) were cultured in the presence of hu TGFx.
Proliferation was determined using the MTT assay. A prolifera-
tion of 1000o is defined as the OD at 570 rm obtained upon
culture in EF medium with 0.5% FCS. P<0.005 from untreated
control cells for TGFm>0.6 ng ml ' for all responsive cell lines.
was a better mitogen for LS513 than IGF-I or II (Table I).
The sensitivity to TGFx of all four lines was slightly higher
than that to IGF-I or II. To obtain a half-maximal response
1.11-3.31 ng ml-l of TGFa were required and maximal stim-
ulation was obtained with 10-20 ng ml-' already (Table I).
TGFa had no effect on growth of Co-i 15. Lisp-I and
LS1034 (data not shown).
TGFafurther enhances the proliferation effects ofIGF-I
Since responses of IGF-I, II and TGFaE are mediated by
binding to different receptors (Czech, 1989; Wong et al..
1989) we speculated that co-stimulation might even be more
effective than the action of the individual factors. We thus
performed mixing experiments with TGFa and IGF-I. A
suboptimal concentration of TGFa (3 ng ml-') was added to
serial dilutions of IGF-I. The proliferation of all four double-
responsive cell lines was further enhanced when they were
co-stimulated by both factors. On LS513 cells, the response
to the combination of factors was synergistic at every con-
centration of IGF-I tested (Figure 5a). On HT-29 cells, the
effect was additive. However, rising amounts of IGF-I dim-
inished the growth increase induced by TGFa (Figure Sb). A
comparable response was obtained with LS41IN and WiDr
cells (data not shown). On SW480, not responsive to TGFx
alone, the IGF-I-induced proliferation was not further en-
hanced by adding TGFm (data not shown). Furthermore, the
IGF- and TGFa-unresponsive cell lines Co-115 and Lisp-I
did not respond to a combination of IGF-I and TGFax (data
not shown).
Kinetics ofthe action ofTGFa in the co-stimulator} assay
Finally, we attempted to determine whether both factors
needed to be constantly present in order to obtain a full
response using the above co-stimulatory assay. To this effect,
we delayed the addition of TGFa, while IGF-I remained
present for the whole period of stimulation. With LS513 cells
a synergistic response was obtained when both factors were
present throughout the experiment (P<0.05). The response
gradually decreased when the addition of TGFc was further
delayed. However, it retained additive characteristics when
TGFa was present during the last 48 h only. Similarly, the
response of WiDr cells gradually decreased (Table III). How-
ever, even an exposure to TGFa during the last 24 h was
sufficient to enhance proliferation above the value recorded
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Figure 5 TGFcx enhances IGF-I-induced proliferation. The cell
lines a. LS513 and b. HT-29 were cultured in the presence of hu
TGFcx alone (A), rhu IGF-I alone (0) or IGF-I and TGFcx (U).
Proliferation was determined using the MTT assay. Cell prolifera-
tion in the presence of culture medium (0.682 ± 0.026 and
0.565 ± 0.024 for LS513 and HT-29. respectively) was subtracted
for all values. Values represent the mean of triplicates ± s.d.
with IGF-I alone. Surprisingly, the responses of HT-29 and
LS41IN lines were barely modified, regardless of the moment
when TGFa was added. Exposure to TGFz on day 3 only.
yielded a full additive response. The proliferation of LS41IN
was even slightly enhanced by delaying addition of TGFa
(Table III). It is possible that other, yet unidentified factors.
may also play a role in this response.
D6csson
Our data illustrate the role of IGF-I. IGF-11 and TGFcx in
regulating the proliferation of human colorectal carcinomas.
Five out of eight cell lines could be stimulated by IGF-I and
IGF-II and four also responded to TGFcx. In addition.
growth of all double-responsive lines could be further en-
hanced by co-stimulation with IGF-I and TGFa. The IGFs
proved to be the best mitogen on all responsive cell lines.
except LS513. Even low doses of growth factors stimulated
growth significantly. The responsiveness was similar to that
observed for a non-tumourigenic colonic adenoma (Mar-
kowitz et al., 1990) and comparable to results obtained with
tumour cells of other origin, such as pancreatic cancer
(Ohmura et al., 1990) or neuroblastoma (El-Badry et al..
1989) cell lines.
The number of cell lines tested, however, is too small to
allow any statements to be made about a possible correlation
of growth rate and responsiveness to growth factors. All cell
lines with a doubling time of 24 h or less (SW480, HT-29.
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Table HI Kinetics of the action ofTGFx in the co-stimulatory assay
with IGF-I
Addition of TGFa on da}
0 1 2 3 4
HT-29a 207 13 207 12 207± 12 202 9 -
LS41 INb 192±2 10 201 I20 205 26 200+21 -
LS513a 198± 2 189± 5 186 5 177 3 161 7
WiDrb 226 18 217 13 206 14 193+P -
Responses to IGF-I TGFm are expressed as % proliferation ± s.d. in
comparison to untreated control cells. Results represent the mean of
three independent experiments. ap<0.0005. bp<0.005 from untreated
control cells.
WiDr and LS411N) responded to growth factors. compared
to only one among the slowly growing cell lines (LS513). In
addition. optimal growth factor responsiveness was seen to
depend on cell density. Here again. our data may indicate a
correlation with growth rate. The very rapidly growing
SW480 line responded best at a cell density approximately
four times lower than LS513. with a doubling time about
twice as high. In addition. cell lines with growth rates of
medium duration (HT-29. WiDr) were best stimulated at
intermediate cell concentrations.
IGF-I and IGF-I1 are closely related to insulin. Three
types of receptors have been characterised for these mole-
cules. with different binding affinities (Czech. 1989). In our
hands. IGF-I and IGF-II were equally active and stimulated
proliferation to the same extent. indicating that the response
might be mediated through the same receptor. In addition.
the sensitivity of the cell lines to both factors was quite
similar. On the other hand. the response to insulin of HT-29
cells required much higher doses. These results are in good
agreement with the binding affinities of the IGF-I-receptor
(Czech. 1989) and. therefore. our data strongly suggest that
the response of IGF-I and IGF-II was indeed transmitted via
this receptor.
With TGFx. however, another plateau was reached. indi-
cating that this response was mediated by the TGFax EGF-
receptor. Stimulation of different receptors often enhances
the response obtained with a single factor (Durrant et al..
1991: Shipley et al.. 1984). Actually. the proliferation of
colorectal carcinomas was enhanced even further upon simul-
taneous stimulation with IGF-I and TGFx. On HT-29.
LS41 IN and WiDr the effect was additive. while LS513
responded synergistically. One explanation of these results
may be related to different pathways of intracellular signal
transduction. The additivity of the response suggests that
IGF-I and TGFa may act independently to stimulate cell
growth. Similar results have been reported for breast cancer
cells (Wakeling et al.. 1989). In contrast. the pathways might
cooperate intracellularly. thereby potentiating the response.
Another explanation for the different results observed after
co-stimulation would be production of endogenous growth
factors by the tumour cells. namely autocrine growth stim-
ulation. as originally proposed by Sporn and Todaro (1980).
Molecules with potential autocnrne activity. similar or iden-
tical to IGF-I. EGF and TGFa. have been detected in the
supernatant of colon carcinomas (Anzano et al.. 1989: Cul-
ouscou et al.. 1987). Assuming that the tumour cells indeed
secreted such molecules. the stimuli induced by endogenous
and exogenous factors would have been transmitted via the
same types of receptors. Thus. the final outcome could only
be additive. In contrast, the hormone gastnrn was auto-
stimulatory for colon carcinomas but failed to stimulate pro-
liferation when added exogenously (Hoosein et al.. 1990).
However. gastrin synergised in combination with IGF-I and
TGFa (Durrant et al.. 1991).
Indications for the involvement of autocrine growth fac-
tors may be derived from our data.
First. when limiting conditions were used, the addition of
IGF-I and IGF-I1 could be delayed up to 48 h. without
reducing growth of LS41 IN cells using the proliferation
assay. When stimulated with IGF-I as a first signal, a short
(24h) exposure of LS41IN and HT-29 lines to TGFa was
sufficient to obtain an additive response in the co-stimulation
assay. Limiting culture conditions are commonly used to
detect growth factor activities in cell supernatants. Within 2
days. enough material is produced to induce a biological
response (Lahm et al., 1990; Anzano et al.. 1989). It is thus
tempting to speculate that endogenous growth factor produc-
tion may contribute to the final response either by partially
replacing the external stimulus or by cooperating with the
exogenous factor.
Second. IGF-I and IGF-II preferentially stimulated pro-
liferation at low cell density. but were ineffective at high cell
concentrations. This is typical of cell lines secreting autocrine
growth factors and our results agree with those of others
(MarkoWitz et al.. 1990; Scala et al.. 1987).
Third. we have recorded the response daily over a period
of 7 days on two lines. The effect gradually increased, being
maximal on days 4 to 5. It later decreased again as the cells
cultured in the presence of medium accelerated their growth.
More important. preliminary results indicate that long-term
culture of colorectal carcinoma cells under limiting growth
conditions reduces their sensitivity to exogenous growth fac-
tors (data not shown). Taken together, our results suggest
that autocnrne mechanisms may influence the response to
exogenous growth factors, at least in part.
IGF-I. IGF-II and TGFE did not stimulate growth of
three cell lines. either alone or in combination. These lines
may either lack appropriate receptors or produce enough
endogenous growth factor. thereby keeping the receptors per-
manently occupied. Both mechanisms would provide an ex-
planation for the failure of colorectal carcinoma cell lines to
respond to TGFoE and TGFi (Coffey et al.. 1987). In addi-
tion. although they are unresponsive to IGF-I, IGF-II and
TGFa. these lines might be stimulated by other cytokines
which promote growth of colon carcinomas. such as inter-
leukin-3 or hemopoietic colony-stimulating factors (Berdel et
al.. 1989). Finally, DNA alterations are widespread in col-
orectal carcinomas (Fearon & Vogelstein. 1990). Mutations
can result in loss of expression of tumour suppressor genes or
in dysregulation of oncogenes. and p53 (Tanaka et al.. 1991:
Baker et al.. 1990) and c-mvc (Forgue-Lafitte et al.. 1989)
have been shown to regulate growth of colorectal car-
cinomas. Furthermore. an individual cell is frequently muta-
ted at multiple sites. Growth control in such tumours would
indeed be regulated by mechanisms totally independent of,
and possibly refractory to. the influence of any growth fac-
tor.
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